Clinical trial
Incidence and Outcomes Associated With the Management of Adenovirus Infections in Allogeneic Hematopoietic Cell Transplant Recipients: AdVance
NCT04285788 is registered in ClinicalTrials.gov with Jazz Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Incidence and Outcomes Associated With the Management of Adenovirus Infections in Allogeneic Hematopoietic Cell Transplant Recipients: AdVance
- Lead sponsor
- Jazz Pharmaceuticals
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2013
- Completion date
- January 31, 2017
- Enrollment
- 216 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.